India, Feb. 5 -- image credit- freepik

Shukra Pharmaceuticals has received a letter of intent from the Yamuna Expressway Industrial Development Authority (YEIDA) for 10 acres of land in the Medical Device Park, Sector 28, Greater Noida, with a planned investment of approximately Rs 600 crore.

The facility will produce advanced surgical robotics and Boron Neutron Capture Therapy (BNCT) technology, an innovative treatment for complex cancer cases. The project is expected to generate over 900 direct and approximately 2,000 indirect employment opportunities, positioning India at the forefront of health innovation.

Shukra Pharmaceuticals has also signed a Memorandum of Understanding (MoU) with Borns Medical Robotics Inc. to bring cutting-ed...